Cochrane Corner
copied = false, 2000)" class="-mt-1 cursor-pointer flex hover:bg-neutralLight items-center p-1 rounded-sm">
Which Bone-Modifying Agents Are Most Effective in Reducing Bone Loss in Women with Early and Locally Advanced Breast Cancer? - A Cochrane Review summary with commentary
Ekin Ilke Sen1
1.
Department of Physical Medicine and Rehabilitation, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
Keywords
Bisphosphonate Bisphosphonate Bone Loss Bone Loss Breast Cancer Breast Cancer Denosumab Denosumab Quality of Life Quality of Life
The aim of this commentary is to discuss from a rehabilitation perspective the Cochrane Review “Bone modifying agents for reducing bone loss in women with early and locally advanced breast cancer: a network meta-analysis” by Adams et al., published by the Cochrane Breast Cancer Group. This Cochrane Corner is produced in agreement with Journal of Musculoskeletal and Neuronal Interactions by Cochrane Rehabilitation with views of the review summary author in the “implications for practice” section.
Views:
Downloads: